Sai Parenterals IPO is set to close today, but the issue has received a relatively muted response from investors. Subscription levels remained weak during the initial days.
The IPO includes both fresh issue and offer-for-sale components, with funds aimed at expansion and corporate needs. However, grey market trends suggest limited listing enthusiasm.
Market experts believe that ongoing volatility is affecting investor participation in IPOs.
